These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15454841

  • 1. Lymphoblastic leukemia with mature B-cell phenotype in infancy.
    Frater JL, Batanian JR, O'Connor DM, Grosso LE.
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):672-7. PubMed ID: 15454841
    [Abstract] [Full Text] [Related]

  • 2. Lymphoblastic Leukemia With Mature B-Cell Phenotype in Infancy.
    Frater JL, Batanian JR, O'Connor DM, Grosso LE.
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):672-677. PubMed ID: 27811611
    [Abstract] [Full Text] [Related]

  • 3. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.
    Schwartz S, Rieder H, Schläger B, Burmeister T, Fischer L, Thiel E.
    Leukemia; 2003 Aug; 17(8):1589-95. PubMed ID: 12886247
    [Abstract] [Full Text] [Related]

  • 4. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.
    De Zen L, Bicciato S, te Kronnie G, Basso G.
    Leukemia; 2003 Aug; 17(8):1557-65. PubMed ID: 12886243
    [Abstract] [Full Text] [Related]

  • 5. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
    Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ.
    Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
    [Abstract] [Full Text] [Related]

  • 6. Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
    Jabali Y, Starý J, Hak J, Blazek B, Hrstkova H, Mihál V, Mydlil J, Timr P, Gajdos P.
    Med Pediatr Oncol; 2000 Nov; 35(5):493-5. PubMed ID: 11070483
    [No Abstract] [Full Text] [Related]

  • 7. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
    Ramakers-van Woerden NL, Beverloo HB, Veerman AJ, Camitta BM, Loonen AH, van Wering ER, Slater RM, Harbott J, den Boer ML, Ludwig WD, Haas OA, Janka-Schaub GE, Pieters R.
    Leukemia; 2004 Mar; 18(3):521-9. PubMed ID: 14712291
    [Abstract] [Full Text] [Related]

  • 8. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T, Ida K, Bessho F, Hanada R, Kikuchi A, Yamamoto K, Sako M, Tsuchida M, Seto M, Ueda R, Hayashi Y.
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [Abstract] [Full Text] [Related]

  • 9. Mature B-cell lymphoblastic leukemias with MLL gene rearrangements.
    Tsao L, Alobeid B.
    J Pediatr Hematol Oncol; 2005 Apr; 27(4):240. PubMed ID: 15838403
    [No Abstract] [Full Text] [Related]

  • 10. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
    Attarbaschi A, Mann G, König M, Steiner M, Strehl S, Schreiberhuber A, Schneider B, Meyer C, Marschalek R, Borkhardt A, Pickl WF, Lion T, Gadner H, Haas OA, Dworzak MN.
    Clin Cancer Res; 2006 May 15; 12(10):2988-94. PubMed ID: 16707593
    [Abstract] [Full Text] [Related]

  • 11. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.
    Silverman LB, McLean TW, Gelber RD, Donnelly MJ, Gilliland DG, Tarbell NJ, Sallan SE.
    Cancer; 1997 Dec 15; 80(12):2285-95. PubMed ID: 9404706
    [Abstract] [Full Text] [Related]

  • 12. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
    Muñoz L, Nomdedéu JF, Villamor N, Guardia R, Colomer D, Ribera JM, Torres JP, Berlanga JJ, Fernández C, Llorente A, Queipo de Llano MP, Sánchez JM, Brunet S, Sierra J, Spanish CETLAM Group.
    Leukemia; 2003 Jan 15; 17(1):76-82. PubMed ID: 12529663
    [Abstract] [Full Text] [Related]

  • 13. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Pui CH, Chessells JM, Camitta B, Baruchel A, Biondi A, Boyett JM, Carroll A, Eden OB, Evans WE, Gadner H, Harbott J, Harms DO, Harrison CJ, Harrison PL, Heerema N, Janka-Schaub G, Kamps W, Masera G, Pullen J, Raimondi SC, Richards S, Riehm H, Sallan S, Sather H, Shuster J, Silverman LB, Valsecchi MG, Vilmer E, Zhou Y, Gaynon PS, Schrappe M.
    Leukemia; 2003 Apr 15; 17(4):700-6. PubMed ID: 12682627
    [Abstract] [Full Text] [Related]

  • 14. Identification of various MLL gene aberrations that lead to MLL gene mutation in patients with acute lymphoblastic leukemia (ALL) and infants with acute leukemia.
    Pais A, Amare Kadam P, Raje G, Sawant M, Kabre S, Jain H, Advani S, Banavali S.
    Leuk Res; 2005 May 15; 29(5):517-26. PubMed ID: 15755504
    [Abstract] [Full Text] [Related]

  • 15. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
    Pui CH, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, Head DR, Mahmoud HH, Sandlund JT, Furman WL.
    J Clin Oncol; 1994 May 15; 12(5):909-15. PubMed ID: 8164041
    [Abstract] [Full Text] [Related]

  • 16. NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.
    Lopez-Millan B, Sanchéz-Martínez D, Roca-Ho H, Gutiérrez-Agüera F, Molina O, Diaz de la Guardia R, Torres-Ruiz R, Fuster JL, Ballerini P, Suessbier U, Nombela-Arrieta C, Bueno C, Menéndez P.
    Leukemia; 2019 Jul 15; 33(7):1557-1569. PubMed ID: 30635633
    [Abstract] [Full Text] [Related]

  • 17. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH, Kitchen S, Saravia O, Velasquez WS.
    Am J Hematol; 1996 Jan 15; 51(1):85-9. PubMed ID: 8571944
    [Abstract] [Full Text] [Related]

  • 18. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96).
    Isoyama K, Eguchi M, Hibi S, Kinukawa N, Ohkawa H, Kawasaki H, Kosaka Y, Oda T, Oda M, Okamura T, Nishimura S, Hayashi Y, Mori T, Imaizumi M, Mizutani S, Tsukimoto I, Kamada N, Ishii E.
    Br J Haematol; 2002 Sep 15; 118(4):999-1010. PubMed ID: 12199778
    [Abstract] [Full Text] [Related]

  • 19. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
    Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K, Ishii E.
    Blood; 2004 Dec 01; 104(12):3527-34. PubMed ID: 15297313
    [Abstract] [Full Text] [Related]

  • 20. Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.
    Sarashina T, Iwabuchi H, Miyagawa N, Sekimizu M, Yokosuka T, Fukuda K, Hamanoue S, Iwasaki F, Goto S, Shiomi M, Imai C, Goto H.
    Int J Hematol; 2016 Jul 01; 104(1):139-43. PubMed ID: 27084248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.